Delivery and formulation of engineered nucleic acids
US-2024252645-A1 · Aug 1, 2024 · US
US9493790B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9493790-B2 |
| Application number | US-201214238691-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 23, 2012 |
| Priority date | Aug 24, 2011 |
| Publication date | Nov 15, 2016 |
| Grant date | Nov 15, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to methods for constructing a filamentous fungal strain for production of multiple recombinant polypeptides having biological activity. The present invention also relates to methods for producing multiple recombinant polypeptides having biological activity in a filamentous fungal strain. The present invention also relates to filamentous fungal strains expressing multiple recombinant polypeptides having biological activity.
Opening claim text (preview).
What is claimed is: 1. A method for constructing a filamentous fungal strain for production of multiple recombinant polypeptides having biological activity, comprising: (a) replacing an endogenous first gene by targeted integration by introducing into the filamentous fungal strain a first tandem construct comprising (i) a homologous 5′ region of the first gene, a homologous flanking region thereof, or a combination thereof, (ii) one or more first selectable markers, (iii) a first polynucleotide encoding a first polypeptide having biological activity operably linked to a first promoter and a first terminator, (iv) a second polynucleotide encoding a second polypeptide having biological activity operably linked to a second promoter and a second terminator, and (v) a homologous 3′ region of the first gene, a homologous flanking region thereof, or a combination thereof; and (b) replacing an endogenous second gene by targeted integration by introducing into the filamentous fungal strain a second tandem construct comprising (i) a homologous 5′ region of the second gene, a homologous flanking region thereof, or a combination thereof, (ii) one or more second selectable markers, (iii) a third polynucleotide encoding a third polypeptide having biological activity operably linked to a third promoter and a third terminator, (iv) a fourth polynucleotide encoding a fourth polypeptide having biological activity operably linked to a fourth promoter and a fourth terminator, and (v) a homologous 3′ region of the second gene, a homologous flanking region thereof, or a combination thereof; wherein each of the tandem constructs integrates by homologous recombination into the chromosome of the filamentous fungal strain. 2. The method of claim 1 , wherein one or more of the tandem constructs further comprise a first homologous repeat flanking 5′ of the one or more selectable markers and a second homologous repeat flanking 3′ of the one or more selectable markers, wherein the first homologous repeat and the second homologous repeat undergo homologous recombination to excise the one or more selectable markers. 3. The method of claim 1 , wherein the first gene is a cellobiohydrolase I gene. 4. The method of claim 3 , wherein the cellobiohydrolase I gene encodes a cellobiohydrolase I selected from the group consisting of: (i) a cellobiohydrolase I comprising the mature polypeptide of SEQ ID NO: 2; (ii) a cellobiohydrolase I comprising an amino acid sequence having at least 70% sequence identity to the mature polypeptide of SEQ ID NO: 2; (iii) a cellobiohydrolase I encoded by a polynucleotide comprising a nucleotide sequence having at least 70% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 1; and (iv) a cellobiohydrolase I encoded by a polynucleotide that hybridizes under at least high stringency conditions with the mature polypeptide coding sequence of SEQ ID NO: 1 or the full-length complement thereof. 5. The method of claim 1 , wherein the second gene is a cellobiohydrolase II gene. 6. The method of claim 5 , wherein the cellobiohydrolase II gene encodes a cellobiohydrolase II selected from the group consisting of: (i) a cellobiohydrolase II comprising the mature polypeptide of SEQ ID NO: 4; (ii) a cellobiohydrolase II comprising an amino acid sequence having at least 70% sequence identity to the mature polypeptide of SEQ ID NO: 4; (iii) a cellobiohydrolase II encoded by a polynucleotide comprising a nucleotide sequence having at least 70% sequence identity to the mature polypeptide coding sequence of SEQ ID NO: 3; and (iv) a cellobiohydrolase II encoded by a polynucleotide that hybridizes under at least high stringency conditions with the mature polypeptide coding sequence of SEQ ID NO: 3 or the full-length complement thereof. 7. The method of claim 1 , wherein the homologous 5′ region of the first gene, the homologous flanking region thereof, or the combination thereof is at least 50 bp. 8. The method of claim 1 , wherein the homologous 3′ region of the first gene, the homologous flanking region thereof, or the combination thereof is at least 50 bp. 9. The method of claim 1 , wherein the homologous 5′ region of the second gene, the homologous flanking region thereof, or the combination thereof is at least 50 bp. 10. The method of claim 1 , wherein the homologous 3′ region of the second gene, the homologous flanking region thereof, or the combination thereof is at least 50 bp. 11. The method of claim 1 , which further comprises replacing one or more additional endogenous genes each by targeted integration by introducing into the filamentous fungal strain a corresponding tandem construct for each gene comprising (i) a homologous 5′ region of the gene, a homologous flanking region thereof, or a combination thereof, (ii) one or more selectable markers, (iii) a polynucleotide encoding a polypeptide having biological activity operably linked to a promoter and a terminator, (iv) another polynucleotide encoding another polypeptide having biological activity operably linked to another promoter and another terminator, and (v) a homologous 3′ region of the gene, a homologous flanking region thereof, or a combination thereof. 12. The method of claim 2 , wherein the first and second homologous repeats are identical or have a sequence identity of at least 70% to each other. 13. The method of claim 2 , wherein the first and second homologous repeats are each at least 50 bp. 14. The method of claim 2 , wherein upon the excision of the one or more selectable markers, the one or more selectable markers can be reused for replacing the one or more additional endogenous genes each by targeted integration with the corresponding tandem construct for each gene. 15. The method of claim 1 , further comprising transforming the filamentous fungal host cell with a tandem construct comprising (i) one or more selectable markers, (ii) a fifth polynucleotide encoding a fifth polypeptide having biological activity operably linked to a fifth promoter and a fifth terminator, and (iii) a sixth polynucleotide encoding a sixth polypeptide having biological activity operably linked to a sixth promoter and a sixth terminator, wherein the tandem construct integrates by ectopic integration. 16. The method of claim 1 , wherein the polypeptides having biological activity are different polypeptides. 17. The method of claim 1 , wherein two or more of the polypeptides having biological activity are the same polypeptide. 18. The method of claim 1 , wherein the promoters are different promoters. 19. The method of claim 1 , wherein two or more of the promoters are the same promoter. 20. The method of claim 1 , wherein the terminators are different terminators. 21. The method of claim 1 , wherein two or more of the terminators are the same terminator. 22. The method of claim 1 , wherein the filamentous fungal strain is an Acremonium, Aspergillus, Aureobasidium, Bjerkandera, Ceriporiopsis, Chrysosporium, Coprinus, Coriolus, Cryptococcus, Filibasidium, Fusarium, Humicola, Magnaporthe, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Phiebia, Piromyces, Pleurotus, Schizophyllum, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trametes , or Trichoderma strain. 23. The method of claim 22 , wherein the Trichoderma strain is selected from the group consisting of Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei , and Trichoderma vir
hydrolysing O- and S- glycosyl compounds (3.2.1) · CPC title
for fungi · CPC title
Oligoxyloglucan reducing-end-specific cellobiohydrolase (3.2.1.150) · CPC title
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation · CPC title
Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.